Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep626 | Endocrine tumours and neoplasia | ECE2016

Efficiency of cabergoline suppressive therapy in young patients with prolactinoma

Khyzhnyak Oksana , Karachentsev Iurii , Mykytyuk Myroslava , Gogitidze Teona

Aim: The aim is to study the clinical and hormonal peculiarities of PROL (prolactinoma), manifesting in people under the age of 18 and monitoring the effectiveness of suppressive CAB (Cabergoline, Dostinex) therapy during 12 months period.Materials and methods: The total study included 11 patients with PROL, manifesting in childhood. There were also examined 54 healthy volunteers (25 males and 29 females) aged 15–19 to determine the range of normal ...

ea0063p1048 | Pituitary and Neuroendocrinology 3 | ECE2019

Effectiveness of hight doses of cabergoline suppressive therapy in patients with prolactinoma

Khyzhnyak Oksana , Mykytyuk Miroslava , Gogitidze Teona , Nikolaiev Roman , Barabash Nadya , Manska Katerina

Aim: The aim of the study was to investigate the clinical and hormonal effectiveness of different modes of suppressive cabergoline (CAB) therapy during 12 months in patients with prolactinoma.Subjects and methods: It was examined and underwent a 12 month course of treatment by selective dopamine agonist CAB in 61 patients with prolactinoma (PROL) (9 male/ 52 female) aged 16–66 years. There were 40 women with microPROL, 12 with macro&giant PROL; ...

ea0049ep983 | Pituitary - Clinical | ECE2017

Anti-proliferative effects of high doses cabergoline in patients with prolactinoma

Khyzhnyak Oksana , Gogitidze Teona , Mykytyk Miroslava , Karachentsev Iurii , Barabash Nadiya , Manskaya Katerina

The aim of the study: To investigate the anti-proliferative effect of cabergoline (CAB) which was used in different regimes of suppressive therapy during 12 months in patients with prolactinoma (PROL).Subjects and methods: It was examined and underwent a 12 month course of treatment by selective dopamine agonist CAB 61 patients with PROL: microadenoma 42, macro&giant PROL - 19. (52 women/9 men) aged 16–66 years. The total duration of the disease...

ea0056p817 | Pituitary - Clinical | ECE2018

Diurnal melatonin profile in patients with pituitary adenomas

Khyzhnyak Oksana , Mykytyuk Miroslava , Kashkalda Dina , Gogitidze Teona , Barabash Nadiya , Karachentsev Yurii , Manska Katarina , Nikolaiev Roman

Introduction: The role of the pineal gland and its hormone, melatonin, in the regulation of hypothalamo-adenohypophysial system activity is well known. At the same time, studies of the circadian rhythm of melatonin secretion in patients with pituitary adenomas are few in number, because the evaluation of pineal activity is not generally included in the clinical investigation of patients with pituitary tumors.Aim: The present study analyzed the circadian ...